Obstructive sleep apnoea (OSA) is associated with cardiovascular disease. Intermittent hypoxia, endothelial dysfunction and adipose tissue‐mediated inflammation have all been linked to cardiovascular disease in OSA. We therefore explored the… Click to show full abstract
Obstructive sleep apnoea (OSA) is associated with cardiovascular disease. Intermittent hypoxia, endothelial dysfunction and adipose tissue‐mediated inflammation have all been linked to cardiovascular disease in OSA. We therefore explored the effect of OSA on relevant associated blood markers: adrenomedullin (ADM), endocan, endothelin‐1 (ET‐1), resistin and vascular endothelial growth factor (VEGF).
               
Click one of the above tabs to view related content.